Preimplantation genetic testing for BRCA gene mutation carriers: a cost effectiveness analysis

被引：0
|
作者：
Nadav Michaan
Moshe Leshno
Yoni Cohen
Tamar Safra
Shira Peleg-Hasson
Ido Laskov
Dan Grisaru
机构：
[1] Tel Aviv University,Gynecologic Oncology Department, Lis Maternity Hospital, Tel Aviv Sourasky Medical Center, Sackler School of Medicine
[2] Tel Aviv University,Gastro
[3] Tel Aviv University,enterology, Tel Aviv Sourasky Medical Center, Coller School of Management and Sackler School of Medicine
[4] Sackler School of Medicine,In
[5] Tel Aviv University,vitro Fertilization Unit, Lis Maternity Hospital, Tel Aviv Sourasky Medical Center, Sackler School of Medicine
来源：
Reproductive Biology and Endocrinology | / 19卷
关键词：
IFV/PGT-M; BRCA; Cost-effectiveness; Ovarian cancer; Breast cancer;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [21] Strategies for recruitment of relatives of BRCA mutation carriers to a genetic testing program in the Bahamas
    Trottier, M.
    Lunn, J.
    Butler, R.
    Curling, D.
    Turnquest, T.
    Royer, R.
    Akbari, M. R.
    Donenberg, T.
    Hurley, J.
    Narod, S. A.
    CLINICAL GENETICS, 2015, 88 (02) : 182 - 186
  • [22] Preferred cost communicator in BRCA mutation carriers
    Proussaloglou, Ellie
    Rosenthal, Alex
    Raker, Christina
    Wilbur, Jennifer Scalia
    Huang, Allan
    Eurich, Katrin
    Stuckey, Ashley
    Robison, Katina
    GYNECOLOGIC ONCOLOGY, 2022, 166 : S239 - S239
  • [23] Cost effectiveness of the cancer prevention program for carriers of the BRCA1/2 mutation
    de Azevedo Ramos, Marcelo Cristiano
    Azevedo Koike Folgueira, Maria Aparecida
    Maistro, Simone
    Campolina, Alessandro Goncalves
    de Soarez, Patricia Coelho
    de Bock, Geertruida Hendrika
    Dutilh Novaes, Hillegonda Maria
    Estevez Diz, Maria Del Pilar
    REVISTA DE SAUDE PUBLICA, 2018, 52
  • [24] BRCA1 and BRCA2: The genetic testing and the current management options for mutation carriers
    Palma, M
    Ristori, E
    Ricevuto, E
    Giannini, G
    Gulino, A
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2006, 57 (01) : 1 - 23
  • [25] Analysis of Surgical Choice of Patients with Actionable Non-BRCA Carriers in Comparison to BRCA Gene Mutation Carriers
    Miller-Ocuin, Jennifer
    Chiba, Akiko
    Levine, Edward
    Howard-McNatt, Marissa
    ANNALS OF SURGICAL ONCOLOGY, 2020, 27 (SUPPL 2) : S594 - S594
  • [26] IN-VITRO FERTILIZATION WITH PREIMPLANTATION GENETIC TESTING COMPARED WITH DONOR SPERM AND NATURAL CONCEPTIONAMONGMALE ROBERTSONIAN TRANSLOCATION CARRIERS: A COST-EFFECTIVENESS ANALYSIS.
    Melville, Sam J. F.
    Mandelbaum, Ava D.
    Shi, Jeanne
    Kornfield, Molly S.
    Hersh, Alyssa R.
    Caughey, Aaron B.
    Krieg, Sacha A.
    FERTILITY AND STERILITY, 2024, 122 (04) : E172 - E173
  • [27] Cost-effectiveness of genetic testing for BRCA1 and BRCA2 mutations
    Ozanne, E. M.
    Cipriano, L.
    Cameron, M.
    Newman, T.
    Esserman, L. J.
    CANCER RESEARCH, 2009, 69 (02) : 377S - 377S
  • [28] Cost-effectiveness of alternating magnetic resonance imaging and digital mammography screening in BRCA1 and BRCA2 gene mutation carriers
    Chubiz, Jessica E. Cott
    Lee, Janie M.
    Gilmore, Michael E.
    Kong, Chung Y.
    Lowry, Kathryn P.
    Halpern, Elkan F.
    McMahon, Pamela M.
    Ryan, Paula D.
    Gazelle, G. Scott
    CANCER, 2013, 119 (06) : 1266 - 1276
  • [29] COST-EFFECTIVENESS ANALYSIS OF PREIMPLANTATION GENETIC TESTING FOR ANEUPLOIDY (PGT-A) IN GOOD PROGNOSIS PATIENTS
    Dunn, Ariel J.
    Flannagan, Kerry S. J.
    Hunkler, Kiley
    Hill, Micah J.
    Romanski, Phillip A.
    Torrealday, Saioa
    Diribe, Chinormso
    Lewis, Terrence D.
    DeCherney, Alan
    Devine, Kathleen
    Levy, Michael
    Combs, Joshua C.
    FERTILITY AND STERILITY, 2024, 122 (04) : E5 - E6
  • [30] Towards more effective and equitable genetic testing for BRCA1 and BRCA2 mutation carriers
    James, P. A.
    Harris, M.
    Lindeman, G. J.
    Mitchell, G.
    JOURNAL OF MEDICAL GENETICS, 2008, 45 (11) : 765 - 766
12345